Along with keeping these strategies in mind, it is also important to remember that different formats – digital, print, audio, ...

SearchGPT has the potential to fundamentally change how people seek and discover information. For pharma companies, failing ...

A new biotech start-up – Ouro Medicines – launched today with $120 million in funding from a Series A and a plan to develop ...

Researchers in the US have shown that an artificial intelligence algorithm trained to analyse video recordings of sleep tests ...

In October, Intellia reported phase 2 results with NTLA-2002 – which is pitching to become the first approved in vivo CRISPR ...

A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today with ...

It comes after Mangione was previously charged with the lesser charge of second-degree murder, as well as possession of an unlicensed firearm, forgery, and providing false identification to police.

At its third attempt, Mesoblast has secured FDA approval for Ryoncil as a treatment for children with graft-versus-host disease, the first-ever approval for a mesenchymal stromal cell (MSC ...

In a new report, ‘Helping others: unlocking the potential of ‘other’ cancers through predictive analytics’, the Concr team – co-founders Matthew Foster and Matthew Griffiths, together ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbar radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possible’.

Eli Lilly's Zepbound has become the first drug to be FDA-approved for obstructive sleep apnoea (OSA), a sleep-related breathing disorder that is most common in people who are overweight and ...